Meeder Asset Management Inc Edwards Lifesciences Corp Transaction History

Meeder Asset Management Inc

$1.58 Billion
Q1 2024

A detailed history of Meeder Asset Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meeder Asset Management Inc holds 154 shares of EW stock, worth $14,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154

Holding current value

$14,224

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$72.54 - $95.56 $11,171 - $14,716	154 New	154 $14,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $741,191 - $948,898	-10,852 Reduced 99.97%	3 $0
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $9,307 - $12,123	113 Added 1.05%	10,855 $897,000
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $6,055 - $8,978	-70 Reduced 0.65%	10,742 $1.02 Million
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $1.1 Million - $1.39 Million	10,812 New	10,812 $1.27 Million

Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $731,187 - $898,294	-6,874 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $79,343 - $94,640	771 Added 12.63%	6,874 $778,000
Q2 2021 Aug 09, 2021	SELL	$83.84 - $104.76 $1.52 Million - $1.9 Million	-18,166 Reduced 74.85%	6,103 $632,000
Q1 2021 Apr 28, 2021	BUY	$78.68 - $90.67 $1.55 Million - $1.79 Million	19,713 Added 432.68%	24,269 $2.03 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $1.25 Million - $1.59 Million	-17,375 Reduced 79.23%	4,556 $416,000
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $550,420 - $716,308	-8,192 Reduced 27.2%	21,931 $1.75 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $1.56 Million - $2.09 Million	27,132 Added 907.12%	30,123 $2.08 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $18,710 - $28,917	357 Added 13.55%	2,991 $563,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $116,082 - $132,903	1,619 Added 159.51%	2,634 $614,000
Q3 2019 Oct 17, 2019	SELL	$61.55 - $75.43 $1,231 - $1,508	-20 Reduced 1.93%	1,015 $223,000
Q2 2019 Aug 05, 2019	BUY	$55.74 - $64.41 $19,063 - $22,028	342 Added 49.35%	1,035 $191,000
Q1 2019 Apr 16, 2019	BUY	$47.89 - $64.05 $19,443 - $26,004	406 Added 141.46%	693 $133,000
Q4 2018 Jan 17, 2019	SELL	$46.41 - $56.94 $53,835 - $66,050	-1,160 Reduced 80.17%	287 $44,000
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $26,506 - $33,657	-580 Reduced 28.61%	1,447 $0
Q2 2018 Jul 24, 2018	BUY	$42.45 - $51.3 $50,091 - $60,534	1,180 Added 139.32%	2,027 $0
Q1 2018 May 03, 2018	BUY	$37.19 - $47.45 $929 - $1,186	25 Added 3.04%	847 $118,000
Q4 2017 Feb 02, 2018	SELL	$33.79 - $39.39 $42,169 - $49,158	-1,248 Reduced 60.29%	822 $93,000
Q3 2017 Oct 20, 2017	BUY	$36.29 - $38.83 $75,120 - $80,378	2,070	2,070 $226,000

Others Institutions Holding EW

# of Institutions

1,375

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Edwards Lifesciences Corp Transaction History